These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 17229909

  • 21. Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report.
    Gong D, Ji D, Zhang K, Huang X, Huang G, Xu B, Liu Z.
    Hemodial Int; 2013 Oct; 17(4):618-23. PubMed ID: 23113894
    [Abstract] [Full Text] [Related]

  • 22. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
    Nowrousian MR, Brandhorst D, Sammet C, Kellert M, Daniels R, Schuett P, Poser M, Mueller S, Ebeling P, Welt A, Bradwell AR, Buttkereit U, Opalka B, Flasshove M, Moritz T, Seeber S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8706-14. PubMed ID: 16361557
    [Abstract] [Full Text] [Related]

  • 23. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P, Cook M.
    Adv Chronic Kidney Dis; 2012 Sep 15; 19(5):324-32. PubMed ID: 22920643
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S.
    PLoS One; 2015 Sep 15; 10(10):e0140463. PubMed ID: 26466100
    [Abstract] [Full Text] [Related]

  • 25. Severe renal failure in multiple myeloma.
    Cosio FG, Pence TV, Shapiro FL, Kjellstrand CM.
    Clin Nephrol; 1981 Apr 15; 15(4):206-10. PubMed ID: 7237869
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.
    Curti A, Schwarz A, Trachsler J, Tomonaga Y, Ambühl PM.
    PLoS One; 2016 Apr 15; 11(7):e0159942. PubMed ID: 27467401
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma exchange therapy in acute renal failure due to light chain myeloma.
    Zucchelli P, Pasquali S, Cagnoli L, Rovinetti C.
    Trans Am Soc Artif Intern Organs; 1984 Apr 15; 30():36-9. PubMed ID: 6442807
    [No Abstract] [Full Text] [Related]

  • 31. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E.
    Rinsho Ketsueki; 2006 Apr 15; 47(4):303-9. PubMed ID: 16715965
    [Abstract] [Full Text] [Related]

  • 32. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
    Manohar S, Nasr SH, Leung N.
    Curr Hematol Malig Rep; 2018 Jun 15; 13(3):220-226. PubMed ID: 29725932
    [Abstract] [Full Text] [Related]

  • 33. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
    Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD, Jesky MD, Storr M, Wessels J, Winearls CG, Weisel K, Heyne N, Cook M.
    Lancet Haematol; 2019 Apr 15; 6(4):e217-e228. PubMed ID: 30872075
    [Abstract] [Full Text] [Related]

  • 34. The double polymethylmethacrylate filter (DELETE system) in the removal of light chains in chronic dialysis patients with multiple myeloma.
    Santoro A, Grazia M, Mancini E.
    Blood Purif; 2013 Apr 15; 35 Suppl 2():5-13. PubMed ID: 23676829
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J, Sydor A, Jurczyszyn A, Zabawa-Hołyś S, Nowak J, Czapkowicz-Gryszkiewicz L, Sułowicz W.
    Przegl Lek; 2010 Apr 15; 67(7):547-50. PubMed ID: 21387773
    [Abstract] [Full Text] [Related]

  • 38. Treatment of acute kidney injury with cast nephropathy.
    Walther C, Podoll AS, Finkel KW.
    Clin Nephrol; 2014 Jul 15; 82(1):1-6. PubMed ID: 24725380
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.